NCT00655837 · Interventional trial
Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL
Overall registry status Completed
Phase 1
Conditions Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory